ThunderBio Innovation
Developer of microfluidic technology for diagnosis and research. The company has developed microfluidic chip (lab on a chip) digital liquid biopsy techniques, for the development and diagnosis of instruments and reagents. The product portfolio includes a digital PCR instrument, Biochip analyzer-droplet reader, droplet generator, constant pressure pump, and reagent kits like digital PCR oil phase composition, digital…
Funding snapshot
About
Developer of microfluidic technology for diagnosis and research. The company has developed microfluidic chip (lab on a chip) digital liquid biopsy techniques, for the development and diagnosis of instruments and reagents. The product portfolio includes a digital PCR instrument, Biochip analyzer-droplet reader, droplet generator, constant pressure pump, and reagent kits like digital PCR oil phase composition, digital PCR Kit, nucleic acid extraction kit, thermostatic amplification kit. Founded in The company operates in Life Sciences > Life Sciences Platforms and Tools, Life Sciences > Genomics. Its business models include Genomics > Enabling Technologies > Kits and Reagents > Basic Molecular Biology, Life Sciences Platforms and Tools > Instruments > Diversified. Founded in 2018. Headquartered in China, Jiaxing. The company has raised funding at the Series B stage. Backed by investors including Detong Capital, bftfund.com, Luxin Venture Capital, Zhuopu Investment, Guangzhou Financial Holdings, Daohe Technology Investment, Shenzhen Chenmuyun Technology, BridgeOne Capital, Shanghai Simple Investment Center, the Guangzhou Jinkong.
Business model
Genomics > Enabling Technologies > Kits and Reagents > Basic Molecular Biology,
Life Sciences Platforms and Tools > Instruments > Diversified
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like ThunderBio Innovation?
Analyze your pitch deck before your next raise.
Analyze My Deck →